Medicare Enrolled
Dr. Craig Perlman, D.O.
Endocrinology · Bethpage, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perlman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perlman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perlman
Dr. Craig Perlman is an endocrinology specialist in Bethpage, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Perlman performed 4,491 Medicare services across 3,097 unique beneficiaries.
Between the years covered by Open Payments, Dr. Perlman received a total of $108,564 from 65 pharmaceutical and/or device companies across 1470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perlman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 15% volume in NY
$108,564 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,491
Medicare services
Top 15% in NY for endocrinology
3,097
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~250 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,407 | $112 | $500 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
651 | $31 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
625 | $72 | $600 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
344 | $138 | $500 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
280 | $115 | $400 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
278 | $82 | $400 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
275 | $95 | $350 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
236 | $158 | $850 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
157 | $149 | $550 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
104 | $120 | $500 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
52 | $58 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $12 | $250 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
28 | $130 | $450 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $84 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$108,564
Total received (2018-2024)
Avg $15,509/year across 7 years
Top 6% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
1,470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80,476 (74.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,508 (21.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,580 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,202
2023
$9,035
2022
$3,965
2021
$5,572
2020
$22,642
2019
$19,398
2018
$43,749
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Xeris Pharmaceuticals, Inc.
$493
CeQur Corporation
$330
Novo Nordisk Inc
$313
Lilly USA, LLC
$292
Dexcom, Inc.
$282
Intra-Sana Laboratories
$216
Mannkind Corporation
$192
Abbott Laboratories
$192
Amneal Pharmaceuticals LLC
$185
Boehringer Ingelheim Pharmaceuticals, Inc.
$177
Amgen Inc.
$143
Bayer Healthcare Pharmaceuticals Inc.
$130
Medtronic, Inc.
$123
Antares Pharma, Inc.
$110
SANOFI-AVENTIS U.S. LLC
$110
Corcept Therapeutics
$109
Radius Health, Inc.
$97
ABBVIE INC.
$92
Verity Pharmaceuticals Inc.
$83
PFIZER INC.
$76
BETA BIONICS, INC.
$71
AstraZeneca Pharmaceuticals LP
$71
Insulet Corporation
$69
Alexion Pharmaceuticals, Inc.
$62
Tandem Diabetes Care, Inc.
$39
Avvisto Therapeutics, LLC
$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$36
Amphastar Pharmaceuticals, Inc.
$23
IBSA Pharma Inc.
$19
Regeneron Healthcare Solutions, Inc.
$19
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 27.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$30,860
AstraZeneca Pharmaceuticals LP
$29,700
Lilly USA, LLC
$21,373
Intuity Medical Inc
$5,539
SANOFI-AVENTIS U.S. LLC
$3,275
Novo Nordisk Inc
$1,462
Dexcom, Inc.
$1,462
Abbott Laboratories
$1,247
Xeris Pharmaceuticals, Inc.
$1,203
Tandem Diabetes Care, Inc.
$1,107
Amgen Inc.
$811
Mannkind Corporation
$667
MannKind Corporation
$651
Insulet Corporation
$558
CeQur Corporation
$548
Amarin Pharma Inc.
$530
Antares Pharma, Inc.
$530
Radius Health, Inc.
$528
Medtronic, Inc.
$454
Merck Sharp & Dohme Corporation
$412
Medtronic MiniMed, Inc.
$401
IBSA Pharma Inc.
$372
Amneal Pharmaceuticals LLC
$367
Corcept Therapeutics
$360
Intra-Sana Laboratories
$276
AbbVie Inc.
$269
ABBVIE INC.
$253
Shire North American Group Inc
$232
Janssen Pharmaceuticals, Inc
$210
AbbVie, Inc.
$185
Becton, Dickinson and Company
$178
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$168
Endo Pharmaceuticals Inc.
$166
PFIZER INC.
$164
Horizon Therapeutics plc
$145
Amryt Pharma Holdings Ltd
$138
Bayer Healthcare Pharmaceuticals Inc.
$130
Companion Medical, Inc.
$116
Gemini Laboratories, LLC
$107
DEXCOM, INC.
$105
Alexion Pharmaceuticals, Inc.
$105
LIFESCAN, INC.
$96
Currax Pharmaceuticals LLC
$95
Bigfoot Biomedical Inc
$94
EISAI INC.
$89
Zealand Pharma US, Inc.
$85
Verity Pharmaceuticals Inc.
$83
Supernus Pharmaceuticals, Inc.
$80
Nalpropion Pharmaceuticals LLC
$75
LifeScan, Inc.
$74
BETA BIONICS, INC.
$71
Merck Sharp & Dohme LLC
$55
Amphastar Pharmaceuticals, Inc.
$36
Avvisto Therapeutics, LLC
$36
Kowa Pharmaceuticals America, Inc.
$35
Eisai Inc.
$35
Acerus Pharmaceuticals Corporation
$33
Regeneron Healthcare Solutions, Inc.
$19
Clarus Therapeutics Inc.
$18
Nevro Corp.
$18
Embecta Corp.
$17
Alnylam Pharmaceuticals Inc.
$16
Nalpropion Pharmaceuticals, Inc.
$15
VistaPharm, Inc.
$15
VIVUS, Inc.
$9
Top 3 companies account for 75.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD ULTRA-FINE · BD Ultra-Fine · BYDUREON · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Corlanor · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVKEEZA · FARXIGA · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle InsuLinx system · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LOKELMA · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Natesto · ONETOUCH VERIO REFLECT · ONPATTRO · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · One Touch Reveal Mobile App · Otrexup · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TESTOPEL · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · Vascepa · Wegovy · XIAFLEX · XIGDUO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for endocrinology in NY.
Geographic Context
Endocrinologists within 10 mi
407
Per 100K population
29.3
County median income
$143,408
Nearest hospital
CHSLI ST JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perlman is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with speaking/promotional industry engagement in the top 6% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perlman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Perlman performed 1,407 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perlman receive payments from pharmaceutical companies?
Yes. Dr. Perlman received a total of $108,564 from 65 companies across 1,470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perlman's costs compare to other endocrinologists in Bethpage?
Dr. Perlman's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perlman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Bethpage
Browse endocrinologists in Bethpage ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology